Wuhan Thalys Med Tech Co Ltd Capital Reinvestment Ratio
Wuhan Thalys Med Tech Co Ltd capital reinvestment ratio. Wuhan Thalys Med Tech Co Ltd (603716) has a Capital Reinvestment Ratio of 0.03x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥54.57 Million) in capital expenditures (CN¥1.57 Million). Check cash flow reinvestment rate of Wuhan Thalys Med Tech Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Wuhan Thalys Med Tech Co Ltd (2012–2024)
Capital reinvestment ratio of Wuhan Thalys Med Tech Co Ltd from 2012 to 2024. This chart tracks Wuhan Thalys Med Tech Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Also explore net asset momentum of Wuhan Thalys Med Tech Co Ltd to track the company's year-over-year net asset growth rate.
Wuhan Thalys Med Tech Co Ltd Capital Reinvestment Ratio by Year (2012–2024)
Wuhan Thalys Med Tech Co Ltd capital reinvestment ratio by year from 2012 to 2024. For the full cash flow conversion analysis, see how efficiently does Wuhan Thalys Med Tech Co Ltd generate cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.23x | CN¥99.60 Million | CN¥23.21 Million | ▼ -28.1% |
| 2023 | 0.32x | CN¥125.89 Million | CN¥40.83 Million | ▼ -83.3% |
| 2022 | 1.94x | CN¥28.12 Million | CN¥54.64 Million | ▼ -84.9% |
| 2020 | 12.84x | CN¥9.94 Million | CN¥127.70 Million | ▲ +1150.0% |
| 2019 | 1.03x | CN¥93.92 Million | CN¥96.49 Million | ▲ +17.0% |
| 2015 | 0.88x | CN¥46.11 Million | CN¥40.47 Million | ▼ -16.8% |
| 2014 | 1.06x | CN¥30.07 Million | CN¥31.73 Million | ▼ 0.0% |
| 2013 | 1.06x | CN¥32.54 Million | CN¥34.35 Million | ▼ -93.1% |
| 2012 | 15.20x | CN¥2.70 Million | CN¥41.04 Million | — |